Brooks Laboratories (NSE:BROOKS) ROCE % : -55.38% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Brooks Laboratories's annualized ROCE % for the quarter that ended in Mar. 2024 was -55.38%.

Brooks Laboratories ROCE % Historical Data

The historical data trend for Brooks Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories ROCE % Chart

Brooks Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

-8.74

-5.59

-17.16

-32.37

-26.01

Brooks Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-27.87	-21.49	-7.33	-17.84	-55.38

Brooks Laboratories ROCE % Calculation

Brooks Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-187.211	/	( ( (1095.973 - 330.213)	+	(904.454 - 230.476) )	/ 2 )
	=	-187.211	/	( (765.76	+	673.978)	/ 2 )
	=	-187.211	/	719.869
	=	-26.01 %

Brooks Laboratories's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-373.264	/	( ( (0 - 0)	+	(904.454 - 230.476) )	/ 1 )
	=	-373.264	/	( ( 0	+	673.978 )	/ 1 )
	=	-373.264	/	673.978
	=	-55.38 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Brooks Laboratories (NSE:BROOKS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Brooks Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Brooks Laboratories (NSE:BROOKS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » ROCE %

Traded in Other Exchanges

533543:India

Address

Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093

Website

https://www.brookslabs.net

Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (NSE:BROOKS) Headlines

No Headlines